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Trypanosoma cruzi, the etiological agent of Chagas' disease, produces wide- 
spread  infections in  man  and  animals,  parasitizing a  variety of cell types, 
including those of the myocardium. In this and other sites,  accumulation of 
lymphocytes and  macrophages are  common (1), thus  leading  a  number  of 
investigators to suggest a role for cell-mediated immunity in resistance to the 
parasite.  The presence of delayed hypersensitivity in humans (2) and experi- 
mental animals (3) as well as inhibition of leukocyte migration (4) are consist- 
ent with this concept. In addition, suggestions that partial protection can be 
conferred by transfer of spleen cells from immune donors (5, 6) and the resist- 
ance of peritoneal macrophages to in vitro parasitization after infection with 
either T. cruzi or BCG are in keeping with a cellular mechanism (7). 
Prior work from this laboratory has defined conditions whereby trypomasti- 
gotes may be separated from mixed culture forms of T. cruzi (8). Epimastigotes 
taken  up  by  resident,  unstimulated  macrophages  are  promptly  destroyed, 
whereas trypomastigotes survive quantitatively and replicate in the cytoplasm 
of both normal and thioglycollate-induced macrophages (9). 
In this paper we examine the property of macrophages obtained from animals 
infected with both T. cruzi and BCG, first in terms of  their microbicidal activity 
against trypomastigotes of T. cruzi and second in terms of other parameters of 
macrophage activation, such as secretion ofplasminogen activator and phagocy- 
tosis mediated by the C3 receptor. 
Materials and Methods 
Parasites.  The Y strain of T.  cruzi  was obtained from Dr. S.  C. Correa, Instituto Oswaldo 
Cruz, Rio de Janeiro, Brazil, and the Tulahudn strain from Dr. B. Bloom, Albert Einstein School 
of Medicine, Bronx, N. Y. The parasites were grown in Tobie's medium and passed weekly (10). 
Parasites  were  harvested  from  8-day-old  cultures,  washed five times in ice-cold  phosphate- 
buffered saline (PBS)  1 (Dulbecco's; Grand Island Biological Co., Grand Island, N. Y.) at 750g for 
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1  Abbreviations  used in this paper: AT, acid treated; CM, conditioned medium; D10, Dulbecco's 
medium containing 10% heat-inactivated bovine serum; D20STI, Dulbecco's medium containing 
20%  heat-inactivated bovine serum and 60  ~g/ml soybean trypsin inhibitor: E(IgM)C,  sheep 
erythrocytes coated with anti-sheep erythrocyte IgM and complement; FBS, fetal bovine serum; 
HBSS,  Hanks' balanced salt solution; HKT, heat-killed trypanosomes; H37Ra,  strain H37Ra of 
Mycobacterium  tuberculosis;  PBS, phosphate-buffered saline; PMNs,  polymorphonuclear leuko- 
cytes; PP, proteose-peptone;  PPD, purified protein derivative of tuberculin; STI, soybean trypsin 
inhibitor. 
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15 min, resuspended in ice-cold PBS or Dulbecco's modified Eagle's medium (GIBCO) and counted 
in a hemocytometer with a 40 x  objective. The cultures of Y strain contained 85% epimastigotes 
and 15% trypomastigotes. The Tulahudn strain contained 95% epimastigotes. Purified trypomasti- 
gotes were obtained as previously described (8). 
Cell Culture 
NORMAL MACROPHAGES.  Mouse peritoneal macrophages were obtained from Swiss mice main- 
tained at The Rockefeller University, and C57BL/6J, A/J, and C3H/HeJ mice obtained from The 
Jackson Laboratory, Bar Harbor, Maine. Cells were harvested according to the methods of Cohn 
and  Benson  (11)  and plated  either on  13-mm round cover  slips  in  Dulbecco's plus  10%  heat- 
inactivated fetal bovine serum (FBS), 100 U/ml penicillin and 100/~g/ml streptomycin (D10), or in 
~s~I-fibrin-coated 16-ram Linbro plates  (Linbro Chemical Co., New Haven,  Conn.) in Dulbecco's 
plus  20%  heat-inactivated  FBS,  60  /~g/ml  soybean  trypsin  inhibitor  (STI,  fraction  VI;  Miles 
Laboratories, Inc., Miles Research Div., Kankakee, Ill.), to suppress fibrinolysis, and antibiotics, 
as above (D20STI). The average yield of cells obtained from normal mice was 5 ×  10  e, of which 45- 
50% were macrophages. Serial dilutions of cells were plated for most experiments, ranging from 1 
x  105 to 108 cells per well. 
IMMUNE MACROPHAGES.  Immune  macrophages  were  obtained from  animals  previously  in- 
fected intraperiteneally with 5  ×  108 live culture forms of T. cruzi, Y strain, in PBS, collected as 
described above or from animals infected intravenously with 2-6 x  107 viable BCG (strain 1011; 
Trudeau Institute, Inc., Saranac Lake, N. Y.). Animals were kept in large plastic cages, usually 
six per cage. Controls were kept under the same conditions for the same period of time. Cells were 
harvested, at different times after the infection, from the peritoneal cavity with or without an 
intraperitoneal challenge with the following agents: (a) heat-killed trypanosomes (HKT), 5 ×  106 
culture forms of the Y or Tulahudn strain, heated at 80°C for 10 min, in PBS. (b) Mycobacterium 
tuberculosis, strain H37Ra, (lyophilized; Difco Laboratories, Detroit, Mich.). Stock solutions were 
sonicated, 2 mg/ml in PBS plus 0.1% bovine serum albumin and 400/~g in 1 ml PBS injected per 
mouse.  (c) Purified protein derivative of tuberculin (PPD) (Connaught Medical Research Labora- 
tory, Willowdale, Ontario, Canada), 50/~g in i ml PBS. (d) Proteose-peptone (PP) (Difco Laborato- 
ries), 1 ml of a  1% solution. 
Cells were cultivated as described above for normal macrophages for 24 h  before assays were 
started. Serial dilutions of cells were plated for most experiments, ranging from 105 to 106 cells per 
well. Average yields were: 10 x  106 cells per mouse for control challenged animals and 15-20 x  105 
for immune, boosted animals from which 70-75% were macrophages and 20-25% polymorphonu- 
clear leukocytes (PMNs) at day 2.  Immune resident cells were 10  x  106 per mouse,  from which 
45-50% were macrophages, 45-50% lymphocytes, and about 5% PMNs. 
Assays 
FIBRINOLYSIS ASSAY.  Fibrinolysis was  assayed  on  ~25I-fibrin-coated 16-mm  Linbro plates as 
described elsewhere (12). The plates contained 10/~g fibrinogen/cm  2 and 5 x  105 trypsin-releasable 
cpm. Peritoneal cells were plated on 125I-fibrin-coated plates in D20STI. 2 h later nonadherent cells 
were  removed by  washing the  plates three  times  with  Hanks' balanced salt  solution  (HBSS; 
GIBCO); the adherent cells were cultivated for 24 h  in D20STI,  washed three times in HBSS to 
remove inhibitors and dead PMNs, and the assay started by adding 0.5 ml Dulbecco's plus 5% acid- 
treated (AT) dog serum. At this time, the cultures were devoid of granulocytes, as determined by 
microscopic observation. Cultures were monitored at 2 h and 24 h to insure that no fibrinolysis had 
occurred before starting the assay. 50- to 100-~l samples were Withdrawn and assayed for release 
of radioactivity in a Packard Gamma Counter (Packard Instrument Co., Inc., Downers Grove, Ill.). 
Cells were plated in duplicate or in serial dilutions for all the assays.  Results are expressed as 
percent of the total radioactivity releasable/4 h/106 cells. 
Plasminogen activator in conditioned medium (CM) was measured by collecting 50- to 100-~tl 
samples  of cells kept in  serum-free medium  with 0.2%  lactalbumin hydrolysate  for 48 h,  and 
measuring radioactivity  released in the presence and absence of  2 ~g dog plasminogen on labeled 
fibrin plates. Plates contained  95,000 cpm  trypsin-releasable 1251-fibrin; 1 U  =  10%  of total 
radioactivity  releasable/4  h. For measurement in  cell  lysates  cells  were washed twice with HBSS, 
scraped from the dish  in  0.5-1  ml of  0.1% Triton X-I00, and stored  at -20°C, as  described  elsewhere 
(12,  13).  Protein was measured by the method of  Lowry (14)  using egg lysozyme as a standard. NADIA  NOGUEIRA,  SIAMON  GORDON,  AND  ZANVIL  COHN  159 
LYSOZYME ASSAY.  Lysozyme secretion was measured in CM of cells kept in D10 for 48 h, from 
the initial rate of lysis of a  suspension of Micrococcus lysodeikticus  (spray-dried; Miles Laborato- 
ries, Inc., Miles Research Div.) using a  recording spectrophotometer (15). 
Reagents 
AT DOG SERUM.  AT dog serum was prepared by adjusting the pH of dog serum (GIBCO) to 2 
with 2 N  HC1 in isotonic saline; after 30 min at room temperature, the pH was adjusted to 7.4 with 
2 N  NaOH in isotonic saline and filter sterilized (12). 
I~ASMI~OGES.  Plasminogen  was  purified  from  dog  serum  by  affinity  chromatography  on 
lysine-Sepharose according to the method of Deutsch and Mertz (16). 
Preparation of Sensitized Erythrocytes.  Sheep erythrocytes coated with IgM and complement 
[E(IgM)C] and the assay of ingestion were performed as described previously (17,  18). 
Trypomastigote-Killing  Assay.  50 ~l of a suspension of purified trypomastigotes in Dulbecco's 
were added to macrophage monolayers on 13-mm round cover slips, at a  1:1 or 1:2 parasite per cell 
ratio, and incubated for 90-180 min at 37°C.  At the end of the exposure period, cover slips were 
washed extensively to remove all extracellular parasites and either fixed for microscopic observa- 
tion or replenished with complete medium (D10), and incubation continued at 37°C for the desired 
time.  Percentage of macrophages infected,  number of parasites per macrophage,  and total cell 
number were counted in Giemsa-stained samples as previously described (9). 
Results 
The Trypanocidal Activity of Macrophages 
We have previously reported that resident mouse peritoneal macrophages or 
macrophages  obtained  from thioglycollate-stimulated  animals  fail to  kill  the 
trypomastigotes  of T.  cruzi,  whereas  epimastigotes  are  promptly  destroyed 
within  their  phagolysosomes  (9).  This  prompted  us  to  examine  the  role  of 
acquired,  cell-mediated immunity,  elucidated in other systems in the destruc- 
tion of intracellular parasites.  For this purpose, we tested the ability of macro- 
phages from T. cruzi-infected  mice  to  deal with trypomastigotes  in  vitro.  In 
addition, animals were also infected with BCG to examine the specificity of the 
acquired immunity.  Finally, a comparison was made between the resident cells 
of infected animals  and those evoked by a  secondary intraperitoneal  challenge 
with either  HKT, H37Ra antigen,  or a  nonspecific irritant  in the form of PP. 
These results are outlined in Table I. 
Resident macrophages from animals infected with T. cruzi showed no trypan- 
ocidal activity, when compared to macrophages from noninfected controls. How- 
ever, when these animals,  infected with T. cruzi  for 2-6 wk, were challenged 
intraperitoneally  with HKT, their  macrophages were able to destroy approxi- 
mately 70%  of the ingested trypomastigotes.  Similarly,  macrophages  from T. 
cruzi-infected  animals, challenged either with the unrelated antigen H37Ra or a 
nonspecific stimulant,  were also able to kill equal numbers of organisms.  The 
injection of HKT, H37Ra, or PP into noninfected animals was without influence 
on their microbicidal activity. Animals infected with BCG and challenged either 
with HKT or H37Ra antigens  expressed a  lower, but significant,  trypanocidal 
activity compared with cells from animals infected with live trypanosomes. 
Resident  peritoneal  macrophages  from  T.  cruzi-  or  BCG-infected  animals, 
harvested without  a  previous secondary challenge,  displayed a  trypanostatic, 
rather  than  trypanocidal  activity,  as can be seen in Figs.  1 A  and  1 B.  The 
intracellular  parasites  multiply at a  slower rate  in these cells.  It is apparent 160  MACROPHAGE  ACTIVATION 
TABLE  I 
The Influence of Infection and Challenge on the Trypanocidal 
Activity of Cultivated Macrophages* 
Infection  Challenge 
Parasites/100 
No. infected cells  macrophages at  at 24 h  24 h 
(% initial value)$  (% initial value)$ 
wk 
Control  -  118  104 
HKT  97  81 
PP  102  100 
T. cruzi 
3  -  97  95 
2  HKT  28  21 
3  HKT  35  19 
4  HKT  37  22 
6  HKT  33  23 
6  H37  22  18 
4  PP  35  44 
BCG 
3  -  92  82 
3  HKT  72  53 
3  H37  53  42 
* Swiss mice were infected intraperitoneally with 5 ×  106 live culture 
forms ofT. cruzi Y strain, and at different times thereafter challenged 
intraperitoneally  with HKT (5 x  10~), PP (1 ml of a 1% solution), and 
H37Ra  (400 /~g  in  1 ml  PBS).  Cells were  harvested 2 days later, 
nonadherent cells  removed by washing three  times in HBSS,  and 
macrophages cultivated for 24 h in D10 before infection. 
Cells were exposed to purified trypomastigotes at a 1:1 or 1:2 parasite/ 
cell multiplicity for 3 h; under these conditions about 30-35% of the 
original macrophage population is infected.  Values represent num- 
bers at (T 24 h/T 3 h)  × 100. 
that even T. cruzi infection and specific antigenic challenge yielded cell popula- 
tions which  could  not  completely inactivate the  phagocytized  inoculum. The 
surviving 30-40% of the ingested inoculum multiplied at a  slower rate in these 
cells. However, after 72 h  of cultivation, the remaining trypomastigotes in these 
cells, as well as the trypomastigotes in the immune resident cells, were multi- 
plying at  a  normal  rate  and  were  able  to  parasitize  uninfected cells  in the 
monolayer. 
We concluded from these experiments that the peritoneal macrophages from 
infected animals express significant trypanocidal activity only after a secondary 
challenge. In contrast, resident cells from immune animals, obtained without a 
secondary challenge express a  trypanostatic, rather than trypanocidal activity. 
Employing these  systems,  other  parameters  of macrophage  stimulation were 
next examined. NADIA  NOGUEIRA,  SIAMON  GORDON,  AND  ZANVIL  COHN 
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FIG.  1.  The behavior of trypomastigotes of T. cruzi in macrophages from (A) T. cruzi- and 
(B) BCG-infected mice. Peritoneal macrophages from T. cruzi- or BCG-infected Swiss mice 
were harvested 3 wk after infection without (I) or with (IB) an intraperitoneal challenge 
with the respective antigen, 5  x  106 HKT or 400 b~g H37Ra.  24-h explanted macrophages 
were  exposed  to  purified  trypomastigotes  at  a  1:1  multiplicity  for  3  h.  Infection  and 
microscopic evaluation were done as described in the Materials and Methods. Control cells 
(C) are resident peritoneal macrophages from noninfected mice. 
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Macrophage Fibrinolytic Activity After Infection and Challenge with T. 
cruzi 
Prior  work  had  indicated  that  a  plasminogen  activator  was  secreted  by 
macrophages  activated by either  thioglycollate medium  (12) or endotoxin fol- 
lowed by particle  ingestion  (13).  It was therefore of interest to investigate the 
role of infection with intracellular parasites on the secretion of this product. Fig. 
2 A  shows representative  data  on the role of infection and  challenge  with T. 
cruzi on the fibrinolytic activity of cultivated mouse peritoneal macrophages. 
No  significant  increase  in  fibrinolytic  activity  was  found  in  macrophages 
harvested  from  mice  infected  5  wk  previously with  T.  cruzi (I).  However, a 
marked increase  in fibrinolytic activity was found when the infected animals 
had received an intraperitoneal  challenge with HKT 3 days before harvesting. 
These cells (IB) showed a  7- to 15-fold increase over the unstimulated controls 
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FIG.  2.  Effect  of infection and  challenge  with  T.  cruzi  on  the  fibrinolytic activity  of 
cultivated mouse maerophages. Mice were infected 5 wk previously with 5 ×  10  e live culture 
forms ofT. cruzi. Resident peritoneal cells were harvested from infected (I) and control mice 
(C), and from infected (IB) and control (CB) mice which were challenged intraperiteneally 3 
days before with 5 x  l0  s HKT (A). A time-course offibrinolysis is shown in the lower graph 
(B). 
in fibrinolytic activity in some experiments, but after the challenge this activity 
was always enhanced an additional four- to fivefold. In contrast, the intraperito- 
neaI injection of HKT into noninfected controls (CB) yielded only an insignifi- 
cant response although a similar amount of phagocytizable material was intro- 
duced into the cavity. Fig. 2 B illustrates the time-course of fibrinolysis, employ- 
ing cells from the same sources, and shows the prompt and linear reaction of 
infected and boosted populations (IB). 
The appearance of these activated macrophages in the peritoneal cavity after 
a secondary  challenge requires a previous infection (Table II). The injection 3 wk 
before challenge of 5 × 106 HKT is not sufficient to generate macrophages with 
increased fibrinolytic activity. In contrast, infection with the same number of 
viable trypanosomes, followed 3 wk later by the intraperitoneal challenge with 
HKT yields macrophages which display enhanced fibrinolytic activity. 
The Nature and Intracellular Localization of the Fibrinolytic Activity.  The 
nature and distribution of the fibrinolytic activity of these activated macro- NADIA  NOGUEIRA~  SIAMON  GORDON~  AND  ZANVIL  COHN 
TABLE  II 
Fibrinolytic Activity of Macrophages Obtained from Animals 
Receiving Viable or Heat-Killed Trypanosomes* 
Infection  Challenge 
Plasminogen activator, 
% radioactivity re- 




--  1.0 
HKT  1.1 
-  0.9 
HKT  1.8 
-  3.6 
HKT  12.2 
*Mice were either given 5 ×  l0  s live culture forms ofT. cruzi, or 5 ×  l0  s 
heat-killed culture forms by the intraperitoneal route. 3 wk later they 
were  challenged intraperitoneally with 5  x  l0  s HKT  and cells har- 
vested 2 days later. 
TABLE  III 
The Nature and Localization of the Fibrinolytic Activity of Cultivated 
Macrophages* 
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Treatment  Plasminogen activators 
Conditioned 




-  6.2 (0.25)  1.8 (<0.1)  8.0 
+  5.5 (0.03)  1.2 (<0.1)  6.7 
-  20.0 (0.1)  6.7 (<0.1)  27.0 








* Mice were infected intraperiteneally with 5  x  106 culture forms of T. cruzi 
and boosted 2 wk later with 5 x  106 HKT.  Peritoneal cells were harvested 2 
days  after  the  boost  and  macrophages  cultivated  for  2  days  in  medium 
containing FBS. The cultures were then washed and incubated for 2 days in 
serum-free medium. 
$ 50- to 100-/~1 samples were assayed in duplicate -  2/~g dog plasminogen on 
fibrin plates containing 95,000 cpm trypsin-releasable l~I-fibrin. 1 U, 10% of 
total radioactivity releasable/4 h.  Results in parentheses were obtained in 
the absence of added plasminogen. 
phages was next examined. Table III confirmed that fibrinolysis was induced in 
macrophages from immune challenged mice and was strictly dependent upon 
the presence  of added plasminogen.  In addition,  the plasminogen-dependent 
product was largely  (70-80%)  found in the extracellular medium in cells from 
both immune and immune-challenged animals. These findings strongly suggest 
the secretion  of a  plasminogen activator.  Although not illustrated,  lysozyme 
levels were only twofold higher in culture fluids from infected and challenged 
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FIG.  3.  Time-course of the appearance of macrophages with enhanced fibrinolytic activity 
elicited by an intraperitoneal challenge with HKT, during the course of an infection with T. 
cruzi. Cells were harvested 2 days after intraperiteneal challenge. 
Factors  Modifying  the  Secretion  of  Plasminogen  Activator  by  Macro- 
phages.  A  detailed examination was next conducted on the in vivo events 
which modified the expression of fibrinolysis by explanted macrophages. 
THE DURATION OF INFECTION BEFORE CHALLENGE.  Mice were given a suble- 
thal infection and examined over the course of 13 wk. At intervals from 1 to 13 
wk after infection the animals were challenged intraperitoneally with HKT, 
and the peritoneal cells harvested aider 2 days and explanted in vitro. Fig.  3 
demonstrates the rapid elevation of fibrinolytic activity, reaching a maximum 3 
wk after infection and persisting at somewhat lower levels for over 3 too. The 
fibrinolytic activity of the resident peritoneal macrophages from infected ani- 
mals remained unaltered during this period. Spleen size increased 1.5- to 3-fold 
and, in general, paralleled the fibrinolytic activity. 
THE INTRAPERITONEAL CHALLENGE-DOSE AND TIME  OF HARVESTING.  The ef- 
fect of various  amounts of HKT on the fibrinolytic activity of macrophages 
obtained from control and T.  cruzi.infected  animals is seen in Table IV. No 
significant alteration in fibrinolysis occurs in cells obtained from control mice. 
In contrast, macrophages from infected animals, obtained 2 days after chal- 
lenge, expressed four- to sixfold higher activity when injected with 5 × 10  B  HKT 
organisms. Significant stimulation is also seen with 1 × 10  ~ HKT but not with 5 
×  l0  b organisms. 
A number of experiments were performed to evaluate the fibrinolytic activity 
of macrophages obtained 2-4 days after an intraperitoneal challenge with 5 × 
l0  s HKT.  Cells  obtained from noninfected mice exhibited low and constant 
levels of activity 2, 3, and 4 days postchallenge (3.3% cpm released/4 h/10  ~  cells). 
Infected animals, however, exhibited a sharp maximum 2 days ai~r challenge 
(18.9% cpm released/4 h/10  6 cells), decreasing progressively  on days 3 and 4. This 
somewhat surprising reduction in fibrinolytic activity on the 3rd and 4th days 
was associated with poor macrophage viability and the presence of extremely 
vacuolated cells containing phagocytized debris. It should also be noted that 
considerable numbers of granulocytes are present in the 2-day exudates. These 
cells are, however, removed by in vitro cultivation (see Materials and Methods) 
and do not contribute to the macrophage response. NADIA  NOGUEIRA,  SIAMON  GORDON,  AND  ZANVIL  COHN 
TABLE  IV 
Effect of  Challenge Size on the Fibrinolytic Activity of  Cultivated 





Dose of  boost 
Plasminogen activator, 
% radioactivity re- 
leased/4 h/10  e cells 
-  2.1 
5  ×  10  5 HKT  1.9 
1  x  10  s HKT  1.7 
5  x  10  ~ HKT  1.1 
-  3.6 
5  x  10  5 HKT  2.7 
1  x  10  e HKT  8.1 
5  ×  10  e HKT  12.2 
165 
* Mice were infected  intraperitoneally  with 5 x 10  6  live  culture  forms of 
T. cruzi, boosted 3 wk later  with HKT  and the peritoneal cells  har- 
vested 2 days later. 
THE  SECRETION  OF  PLASMINOGEN  ACTIVATOR  BY  OTHER  MOUSE 
STRAINS.  Comparative  studies  were  performed with  other  strains  of mice 
which differed in their susceptibility to infection with T. cruzi. In both the A/J 
(highly susceptible) and C57BL/6J  (less susceptible) similar levels of fibrinolysis 
were observed in infected animals which received an intraperitoneal challenge 
with HKT. 
THE  IMMUNOLOGICAL  SPECIFICITY  OF  THE  PLASMINOGEN  ACTIVATOR  RE- 
SPONSE.  To establish the specificity  of  the secondary  challenge on the induction 
of plasminogen activator secretion, a comparison was made with cells obtained 
either  from BCG- or T. cruzi-infected  animals and noninfectod controls  chal- 
lenged intraperitoneally  with HKT  and PPD. In  addition,  a non-specific  inflam- 
matory agent in  the form of  PP was included  for  the  intraperitoneal  challenge of 
both infected  and noninfected groups of animals. The results  of such experi- 
ments are shown in Table V. 
The intraperitoneal administration of PPD, HKT,  or PP into noninfected 
controls  resulted  in  cells  with low levels  of  fibrinolytic  activity,  similar  to  those 
found  in  control,  noninjected  animals. T. cruzi-infected  animals challenged with 
HKT  or BCG-infected animals challenged with PPD yielded  cells  which ex- 
hibited  a 10- to 15-fold  increase  in fibrinolytic  activity.  In contrast,  intraperito- 
neal challenge with the unrelated antigen or nonspecific  irritant  yielded a less 
dramatic (threefold)  but definite  increase in activity.  The strength of  the re- 
sponse was therefore  closely  related  to  the specificity  of  the challenge antigen as 
well as the previous infected  state  of  the animals. 
Although the majority of the experiments were conducted with animals 
infected with the Y strain  of  T. cruzi, it was noted that intraperitoneal  chal- 
lenge with heat-killed organisms of either the Tulahu6n or Y  strains gave 
similar  results.  This indicates  a close  antigenic  relationship  between these two 
strains  of  T. cruzi. 
Infection and C-Mediated Phagocytosis 
Prior studies had  demonstrated that the  ability of macrophages to  ingest 166  MACROPHAGE ACTIVATION 
TABLE V 
Specificity of ChaUenge on the Fibrinolytic Activity of Cultivated 
Macrophages from Mice Infected with BCG and T. Cruzi* 
Treatment 
Infection  Challenge 
Plasminogen activator, 
% radioactivity re- 
leased/4 h/106 cells 
Control  -  1.8 
PPD  1.6 
HKT  2.5 
PP  1.9 
T. cruzi 
BCG 
-  2.1 
PPD  6.9 
HKT  23.9 
PP  5.6 
-  1.3 
PPD  18.3 
HKT  3.8 
PP  2.4 
* Mice were infected i.v. with 2-6 × 107 viable BCG or i.p. with 5 × 106 
culture forms of T. cruzi. 3 wk later, the animals were challenged i.p. 
with either 50 ~g PPD,  5 ×  106 HKT, or 1 ml of a  1% solution of 
proteose peptone.  Peritoneal cells were harvested 2 days later and 
cultivated for 24 h in D20STI before assayed. 
E(IgM)C was related to their degree of "activation" or stimulation  (17,  18).  To 
examine this under conditions of chronic infection we employed both T.  cruzi 
and  BCG  and  compared  the  level  of C-mediated  ingestion  in  infected  and 
challenged animals.  Table VI outlines the results obtained.  The expression of 
phagocytosis mediated by the C receptor is displayed nonspecifically by immune 
cells with or without challenge,  as well as by cells from noninfected animals 
challenged intraperitoneally with the same inflammatory agents. 
Discussion 
We present data indicating that a sublethal infection with T. cruzi or BCG in 
mice,  followed by  an  intraperitoneal  challenge  with  the  respective  antigen, 
induces  the  appearance  of macrophages  which  display  microbicidal  activity 
against trypomastigotes of T.  cruzi.  These activated macrophages also secrete 
large  amounts  of plasminogen  activator,  exhibit rapid  spreading  on glass  or 
plastic surfaces, and ingest C-coated erythrocytes. 
The trypanocidal  activity  displayed by these  activated  macrophages  is  not 
totally  efficient,  and  a  small  percentage  of the  phagocytized trypomastigote 
inoculum  survives and  multiplies  after  72  h.  If the  cultures  are  followed for 
longer periods of time,  the infection spreads to the  previously resistant  cells. 
This could be due either to a loss of the microbicidal and microbistatic properties 
of the macrophages upon cultivation, or, less likely, to the survival of a resistant 
population of parasites. 
A  previous report by Hoff (7) has indicated that BCG- and T.  cruzi-immune 
macrophages  were  microbicidal in  vitro for culture forms of T.  cruzi.  In this NADIA  NOGUEIRA~  SIAMON  GORDON~  AND  ZANVIL  COHN 
TABLZ VI 
Complement-Mediated Ingestion by Peritoneal Macrophages 
Infection  Challenge  E(IgM)C ingestion,  %* 
Control  -  5 
HKT  31 
PPD  35 
PP  28 
BCG  --  51 
HKT  47 
PPD  54 
PP  Not done 
T. cruzi  -  24 
HKT  76 
PPD  33 
PP  20 
* Cells were kept for 24 h  in Dulbecco's medium containing 2% FBS 
after  explanting,  washed  three  times  in  HBSS,  and  incubated for 
60 min in 1 ml Dulbecco's plus 0.1 ml 1% E(IgM)C. Attachment and 
uptake  of E(IgM)  was  absent  in  all  of the  above groups.  E(IgM)C 
ingestion expressed  as  percent of macrophages  ingesting  >3  sheep 
erythrocytes. 
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system, the T. cruzi-immune cells were resident peritoneal cells obtained with- 
out a secondary challenge. In our experience, such cells do not display microbici- 
dal  activity  against  trypomastigotes,  but  only  a  microbistatic  effect  which 
delays the growth of the parasites.  The  difference in the two reports  may be 
explained by two factors. In HoiTs system, the challenging inoculum consisted of 
total culture forms which contained  only 5-15% trypomastigotes,  and at least 
85% epimastigotes. We have previously shown that epimastigotes are destroyed 
by normal macrophages. In addition, the cells were not followed longer than 72 
h.  Therefore,  it  is  likely  that  the  apparent  microbicidal  activity  was  only 
reflecting intracellular  killing of epimastigotes and inhibition of growth of the 
few trypomastigotes in the ingested inoculum. 
Infections  caused by facultative  intracellular  bacteria  have  been shown to 
provoke an immune response associated with delayed-type hypersensitivity, not 
transmissible  by  serum,  and  resulting  in  the  formation  of immunologically 
committed lymphoid cells and activation of macrophages (19).  Thymus-derived 
lymphocytes have been implicated as the cell population carrying the specificity 
of the response  (20,  21) and macrophages can be activated by them to become 
effectors which can kill a variety of immunologically unrelated organisms (22). 
This may help us to explain the observation that macrophages obtained from 
BCG-infected animals  have  significant  microbicidal  activity against  T.  cruzi 
trypomastigotes  and  is  in  general  consistent with  the  data  of Mackaness  for 
bacterial (23),  and Hoff (7) and Mauel and Behin (24) for protozoan systems. In 
other protozoan systems, authors have stressed the specificity for the microbici- 
dal or microbistatic properties of macrophages (25,  26). 
In  keeping  with  the  prior  observations  of others,  viable  organisms  were 168  MACROPHAGE  ACTIVATION 
necessary to provide a  persisting antigenic load, and immunization  with HKT 
was ineffective in modifying cell-mediated immunity.  In contrast to these other 
bactericidal systems, a  secondary intraperitoneal  challenge was required with 
either  T.  cruzi  or  BCG  infections  to  yield  trypanocidal  macrophages.  The 
conversion of a  trypanostatic to a  trypanocidal effect after the secondary chal- 
lenge of infected animals may depend on at least two factors. First, the intraper- 
itoneal influx of a larger population of sensitized lymphocytes which can in turn 
alter  macrophage  function  (27).  Second,  the  influence  of products  generated 
during the local inflammatory process, which might influence both lymphocytes 
and macrophages. The presence of lymphokines, persisting antigen, and inflam- 
matory products may explain the apparent lack of antigenic specificity elicited 
by the secondary challenge on the trypanocidal activity. 
Macrophages  activated  either  through  the  generation  of an  inflammatory 
environment  or through  microbial  infection display other properties,  such  as 
rapid spreading  on glass or plastic surfaces (28),  increase in lysosomal hydro- 
lases (11), metabolic perturbations, tumoricidal effects (29, 30), and the ingestion 
of C-coated erythrocytes (18). Inflammatory macrophages induced with thiogly- 
collate broth have been shown to secrete large amounts  of neutral  proteases, 
such  as plasminogen  activator  (12),  elastase  (31),  and  collagenase  (32).  Cells 
from  T.  cruzi-  and  BCGoinfected animals,  harvested  after  a  secondary chal- 
lenge,  also secrete enhanced  amounts  of plasminogen  activator.  Both the  in- 
creased secretory activity and trypanocidal activity have a parallel time-course. 
Increased secretion of plasminogen  activator was found as early as 1 wk after 
infection and challenge,  and microbicidal activity was present from the 2nd wk 
on. Peak activity in both cases was found at 3 wk, when spleen size was also very 
enlarged.  However, these two properties are probably not related since thiogly- 
collate-activated macrophages secrete large amounts of plasminogen  activator 
but do not display trypanocidal activity. 
The  induction  of plasminogen  activator  secretion under  the  conditions  em- 
ployed in this study showed a definite immunological specificity in keeping with 
the trypanocidal results.  These findings could not be explained on the basis of 
particle ingestion since a soluble antigen in the form of PPD elicits the response 
in BCG-infected animals.  One explanation for these data is a role for products of 
specifically sensitized lymphoid elements.  This possibility has been examined 
and is presented in the accompanying publication. 
The  cells  obtained  after  a  specific,  secondary  antigenic  challenge  also  ex- 
hibited  a  number  of other properties.  Rapid,  symmetrical  spreading  leads to 
flattened cells with intensely ruffled plasma membrane and numerous pinocytic 
vesicles. This appearance was maintained in culture for many days, even in the 
absence of serum in the medium. If cells were harvested 2 days after challenge, 
their appearance was as that described above. However, harvesting at 3 and 4 
days led to a  population which was heavily vacuolated and which died rapidly 
upon  in  vitro  cultivation.  The  nature  of this  cytotoxic  effect  is  unknown. 
Another attribute  is their  ability to  ingest E(IgM)C  via the  C  receptor.  This 
property,  described initially  with  thioglycollate-induced  populations  does not 
depend  upon  a  specific  antigenic  challenge  and  is  expressed  by noninfected 
animals challenged with all the agents employed. It would seem that this may NADIA  NOGUEIRA,  SIAMON  GORDON, AND  ZANVIL  COHN  169 
be the result of mediators generated during an inflammatory event and is in 
keeping  with  the  prior  observations  on  macrophage  spreading  in  which  C 
components and coagulation factors play significant roles (33). 
Summary 
Infection of mice with Trypanosoma  cruzi  and subsequent intraperitoneal 
challenge with heat-killed trypanosomes elicits peritoneal macrophages which 
display in vitro microbicidal activity against trypomastigotes of T. cruzi. These 
cells also display other activated properties including rapid spreading, intense 
membrane  activity,  secretion  of high  levels  of plasminogen  activator,  and 
ingestion mediated by the C3 receptor. 
An intravenous infection with BCG, followed by an intraperitoneal challenge 
with mycobacterial antigens brings about macrophages with similar properties. 
These criteria of macrophage activation were compared in normal and BCG- or 
T.  cruzi-immune  mice,  with  or  without  an  intraperitoneal  challenge  with 
specific or unrelated antigens. Trypanocidal activity is displayed by both BCG- 
and T. cruzi-immune macrophages after intraperitoneal challenge with either 
antigen. Resident-immune macrophages from both T. cruzi- and BCG-infected 
mice show a trypanostatic, rather than trypanocidal activity. Macrophages from 
noninfected mice, challenged with the same antigens,  show neither trypano- 
static nor trypanocidal activity. 
Increased secretion of plasminogen activator shows a definite immunological 
specificity. Challenge with the specific antigen induces the appearance of macro- 
phages secreting high levels of plasminogen activator, while unrelated antigens 
induce much smaller levels. Noninfected mice challenged with the same anti- 
gens do not display any enhancement in secretion. In contrast, increased spread- 
ing and phagocytosis mediated by the complement receptor are also displayed by 
cells from noninfected mice challenged with any of the agents tested. 
We  want  to  thank  Ms.  Marianne  Polimeni  for excellent technical  assistance  and  Ms.  Grace 
Silvestri for typing the manuscript. 
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